secwatch.observer — SEC 8-K summary ====================================== Issuer: Scribe Therapeutics, Inc. (SCTX) CIK: 0001853921 Form: 8-K Filed at: 2026-07-27T21:08:53+00:00 Accession: 0001193125-26-318263 Event type: other_material Sentiment: positive Materiality: 0.50 Item codes: 5.03, 9.01 LLM model: deepseek-v4-flash:cloud@v2 Scribe Therapeutics adopts amended charter and bylaws upon closing of IPO ------------------------------------------------------------------------- - Filed Amended and Restated Certificate of Incorporation and Bylaws effective July 27, 2026. - Amendments adopted in connection with closing of initial public offering (IPO). - IPO described in final prospectus dated July 23, 2026 (Registration Statement S-1). - Board and stockholders previously approved the amendments prior to IPO closing. - Charter and Bylaws filed as Exhibits 3.1 and 3.2 to this 8-K. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1853921/000119312526318263/0001193125-26-318263-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1853921/000119312526318263/d141508d8k.htm HTML page: https://secwatch.observer/filing/0001193125-26-318263 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer